Skip to main content
. Author manuscript; available in PMC: 2018 Jun 18.
Published in final edited form as: Innate Immun. 2014 Dec 23;21(5):553–561. doi: 10.1177/1753425914564609

Figure 1.

Figure 1

Effect of recombinant human (hLF) or mouse lactoferrin (mLF) on non-infected BMDCs. BMDCs cultured with 100 µg/ml of recombinant human or mouse LF for 72 h were stained for surface expression of MHC II, CD86 and CD80. (A) Example of forward scatter (FS) and side scatter (SS) dot plot and gating strategy. Gated cells for analysis were >98% CD11c+. (B–D) Percent positive population reported using box and whiskers: median, 25% and 75% quartiles, and minimum and maximum. *P < 0.05; **P < 0.01.